As the current study demonstrated that decreases in MAP2, a protein expressed in dendrites, was observed within the CA1 and CA3 sub-regions of the hippocampus, this aligns with previous psychiatric studies showing the significant role the pathophysiology of the hippocampus plays in depression. This evidence concerns the gene MAP2 and depressive symptom measurement.